NCT03896919

Brief Summary

\- Study the impact of HLA-DQ mismatch on acute rejection of Kidney transplantation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 1, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

May 5, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2020

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2020

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

1 year

First QC Date

March 26, 2019

Last Update Submit

May 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Combined incidence of DSA or IA on peripheral blood molecular profiling

    DSA considered as a binary variable (positive or negative), with positivity based on a threshold criteria of Mean Fluorescence Intensity (MFI) approaching 1000. IA will be considered present or absent using a molecular assay.

    Baseline

Secondary Outcomes (1)

  • Incidence of HLA-DQ DSA [ Time Frame: assessed at days 3,7,15,30 post transplantation

    baseline

Study Arms (2)

cases

HLA-DQ mismatched recipient-donor pairs

Diagnostic Test: HLA-DQ by luminex technology in kidney transplantation

control

HLA-DQ matched recipient- donor pairs

Diagnostic Test: HLA-DQ by luminex technology in kidney transplantation

Interventions

HLA typing (DQ) for donor and recipient using Luminex microbead method from EDTA blood sample

casescontrol

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be carried out on (30) renal transplant Recipient- Donor pairs who will be recruited from transplantation unit.

You may qualify if:

  • The patients who will receive renal transplants.

You may not qualify if:

  • Recipients with pre-transplantation desensitization protocols.
  • Recipients with history of previous transplant or pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut U

Asyut, Egypt

Location

Related Links

Study Officials

  • sohair k sayed, prof.doctor

    clinical pathology

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

March 26, 2019

First Posted

April 1, 2019

Study Start

May 5, 2019

Primary Completion

May 5, 2020

Study Completion

May 12, 2020

Last Updated

May 19, 2020

Record last verified: 2020-05

Locations